Have a feature idea you'd love to see implemented? Let us know!
Back to CSTL overview

CSTL Castle Biosciences PE ratio, current and historical analysis

The PE ratio for Castle Biosciences stock stands at 115.73 as of Jan 14, 2025. The calculation is based on the latest EPS of $0.22 and the stock price of $25.46 per share.

CSTL PE ratio history

How has CSTL's PE ratio performed in the past
Average
N/A
Median
N/A
Minimum
N/A
Maximum
N/A

Castle Biosciences PE ratio by year

Year PE ratio Change
2023 N/A N/A
2022 N/A N/A
2021 N/A N/A
2020 N/A N/A
2019 98.2 N/A
2018 N/A N/A
2017 N/A N/A

CSTL average PE ratio chart

What is the average PE ratio of CSTL for the past years
3-year avg
N/A
5-year avg
N/A
10-year avg
N/A
15-year avg
N/A

CSTL PE vs peers

What is CSTL's PE ratio compared to its peers
Stock name PE ratio Market cap
CSTL Castle Biosciences Inc 115.73 $713.07M
OPTN OptiNose Inc N/A $50.28M
OPK Opko Health Inc N/A $1.01B
ORGO Organogenesis Holdings Inc N/A $383.15M

Frequently asked questions

What is Castle Biosciences's PE ratio?

CSTL's price to earnings ratio is 115.73 as of Jan 14, 2025.

Why is Castle Biosciences's PE ratio so high?

CSTL's PE ratio is high because its earnings per share (EPS) is low relative to its stock price.

How is CSTL's PE ratio calculated (Castle Biosciences PE ratio formula)?

To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Jan 14, 2025), Castle Biosciences's share price is $25.46. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $0.22. Therefore, Castle Biosciences's PE ratio for today is 115.73. PE RATIO(115.73) = STOCK PRICE($25.46) / TTM EPS($0.22)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.